Search

Displaying results 1441 - 1450 of 9709 in total
  1. Drug

    Lefleuganan

    go.drugbank.com/drugs/DB21533
    Experimental

    Lefleuganan is a small molecule drug. Lefleuganan has a monoisotopic molecular weight of 1179.78 Da.

  2. Drug

    Orziloben

    go.drugbank.com/drugs/DB21653
    Experimental

    Orziloben is a small molecule drug. Orziloben has a monoisotopic molecular weight of 222.13 Da.

  3. Drug

    Tegeprotafib

    go.drugbank.com/drugs/DB21665
    Experimental

    Tegeprotafib is a small molecule drug. Tegeprotafib has a monoisotopic molecular weight of 326.04 Da.

  4. Drug

    Vamagloxistat

    go.drugbank.com/drugs/DB21666
    Experimental

    Vamagloxistat is a small molecule drug. Vamagloxistat has a monoisotopic molecular weight of 371.11 Da.

  5. Drug

    Milpecitinib

    go.drugbank.com/drugs/DB21676
    Experimental

    Milpecitinib is a small molecule drug. Milpecitinib has a monoisotopic molecular weight of 380.13 Da.

  6. Drug

    Claziprotamide

    go.drugbank.com/drugs/DB21687
    Experimental

    Claziprotamide is a small molecule drug. Claziprotamide has a monoisotopic molecular weight of 374.13 Da.

  7. Drug

    Beraprost

    go.drugbank.com/drugs/DB05229
    Investigational

    Beraprost is a synthetic analogue of prostacyclin, under clinical trials for the treatment of pulmonary hypertension. It is also being studied for use in avoiding reperfusion injury.

  8. Drug

    PA-1050040

    go.drugbank.com/drugs/DB06039
    Experimental

    PA1050040, a second generation HIV-1 maturation inhibitor, is a chemical analog of Bevirimat (BVM). It inhibits virus replication by the same mechanism of action as BVM.

  9. Drug

    ATG-101

    go.drugbank.com/drugs/DB17162
    Investigational

    ATG-101 is a novel PD-L1/4-1BB bispecific antibody that was designed to block the binding of immunosuppressive PD-1/PD-L1 and conditionally induce 4-1BB stimulation, thus activating anti-tumor immune effectors

    Synonyms: PD-L1/4-1BB bispecific antibody
  10. Drug

    Umbilical Cord Blood Hematopoietic Stem Cells

    go.drugbank.com/drugs/DB15723
    Investigational

    UCB contains a large source of hematopoietic stem cells (HSCs) that are capable of self-renewal, have increased sensitivity to various factors, and are able to generate erythroid and myeloid progenitor … Because HUCBC are largely immature, do not express class II HLA antigens, and do not produce as many cytokines and immunoglobulins as adult lymphocytes, transplantation with these cells means low levels